HIMS Hims & Hers Health
- Official Name: HIMS & HERS HEALTH, INC.
- Headquarters: 2269 Chestnut St, #523, SAN FRANCISCO, CA, 94123 US
- CEO: Andrew Dudum
- Website: forhims.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1 | Won by 9.612 | (0.294) - (9.906) | ||
| 2025-07-15 | 1R | Lost by 3.291 | (2.341) - 0.950 | ||
| 2025-07-22 | 2 | Lost by 2.815 | (1.878) - 0.937 | ||
| 2025-07-23 | 1R | Won by 0.624 | 12.559 - 11.935 | ||
| 2025-07-29 | 3 | Won by 13.381 TOTW | 16.305 - 2.924 | ||
| 2025-08-05 | 4 | Lost by 13.139 | (11.552) - 1.587 | ||
| 2025-08-06 | 2R | Lost by 4.909 | (4.273) - 0.636 | ||
| 2025-08-12 | 5 | Lost by 6.752 | (8.088) - (1.336) | ||
| 2025-08-19 | 6 | Lost by 6.156 | (10.111) - (3.955) | ||
| 2025-08-26 | 7 | Won by 4.868 TOTW | 7.499 - 2.631 | ||
| 2025-09-02 | 8 | Lost by 7.645 | (9.218) - (1.573) | ||
| 2025-09-09 | 9 | Won by 8.515 TOTW | 15.666 - 7.151 | ||
| 2025-09-16 | 10 | Won by 9.887 TOTW | 7.326 - (2.561) | ||
| 2025-09-23 | 11 | Won by 13.388 TOTW | 9.202 - (4.186) | ||
| 2025-09-30 | 12 | Lost by 0.874 | 1.291 - 2.165 | ||
| 2025-10-07 | 13 | Won by 2.410 | 2.146 - (0.264) | ||
| 2025-10-14 | 14 | Lost by 3.859 | (6.902) - (3.043) | ||
| 2025-10-21 | 15 | Lost by 9.882 | (7.851) - 2.031 |
Latest News
Yahoo - 2026-10-17
Hims & Hers Health (HIMS) Dropped, So What Is Driving Attention Now?
Hims & Hers Health (HIMS) is back in focus after fresh product news, with Hers Hair now rolling out in the UK as a clinician-led subscription hair...
Yahoo - 2026-10-17
Peptide Rule Change Could Matter For Hims Shares (HIMS)
Hims & Hers Health recently prepared for potential U.S. regulatory changes on peptide compounding by acquiring a California peptide facility and b...
Yahoo - 2026-10-16
Hims And Hers Health (HIMS) Stock May Trade At A Discount Despite Australia Launch
Hims & Hers Health has been a dramatic ride for shareholders over the past few years, yet recent share price weakness now has investors asking whe...
Yahoo - 2026-10-16
What Does Hims & Hers Health (HIMS) Expansion Into The UK And Australia Mean?
Hims & Hers Health (NYSE:HIMS) announced the launch of Hers personalised hair loss and wellness care in the UK in October 2026. The Hers UK rollou...
Yahoo - 2026-10-16
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the st...
Yahoo - 2026-10-16
1 Stock Under $50 with Solid Fundamentals and 2 We Avoid
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their...
Yahoo - 2026-10-15
HIMS Stock Snaps 3-Day Slump On Peptide Hopes: Trump Administration Reviews Plan That Could Unlock $2.2B Market
The plan would apparently temporarily allow specialty pharmacies to compound certain unapproved peptides, including BPC-157.
Yahoo - 2026-10-14
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $27.72, denoting a -6.7% move from the preceding trading day.
Yahoo - 2026-10-14
Hims & Hers Expands Australian Women's Health Platform With Hers
HIMS expands into Australia's women's healthcare market with the Hers launch, offering personalized treatments for weight, hormonal health a...
SeekingAlpha - 2026-10-14
AI Disruption May Benefit Cencora More Than Hims & Hers
Cencora (COR) may gain from AI-driven prescribing volume growth; with strong operating leverage and discounted P/E, see risks and $365 targetârea...
SeekingAlpha - 2026-10-12
Hims & Hers Health: The Bullish Case Is Hard To Forecast, But It Is Asymmetrical
Hims & Hers Health is rated a buy, with a fair value estimate of $41 per share versus the current $29.81. Read more on HIMS stock here.
Yahoo - 2026-10-12
Should You Trim Or Add To Your Hims & Hers Position Now?
Investors holding Hims & Hers Health (HIMS) face a stark contradiction. The stock has lost 52% in twelve months, while the S&P 500 returned 17...
Yahoo - 2026-10-12
Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
SAN FRANCISCO, October 12, 2026--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading global health and wellness platfo...
Yahoo - 2026-10-12
Hers Launches in Australia, Built to Care for the Whole Woman
SYDNEY, October 12, 2026--Hims & Hers, the leading global health and wellness platform, today announced the official launch of Hers in Australia, ...
Yahoo - 2026-10-12
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in ...
Show more
Yahoo - 2026-10-11
Hims & Hers Stock Jumped 10% in a Day as Volume Hit 15.9 Million Shares. Here’s Where the Stock Could Go by 2030
Yahoo - 2026-10-09
1 Healthcare Stock Worth Your Attention and 2 We Turn Down
Yahoo - 2026-10-08
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
Yahoo - 2026-10-07
Hims & Hers Names Jon Franklin as Chief Accounting Officer
SeekingAlpha - 2026-10-07
Cedar Grove Capital Q3 2026 Portfolio Update
Yahoo - 2026-10-07
Hims & Hers Health (HIMS) Investment Thesis: Capturing Market Share in the Cash-Pay Space
SeekingAlpha - 2026-10-07
Tax Gain Harvesting: Tax Alpha With Raul Shah
Yahoo - 2026-10-07
3 Small-Cap Stocks on Our Watchlist
Yahoo - 2026-10-06
2 Cash-Producing Stocks to Research Further and 1 We Find Risky
Yahoo - 2026-10-06
Arboretum Launches to Redefine Precision Medicine for Common Diseases as a Next-Generation Molecular Information Company
Yahoo - 2026-10-05
How Investors May Respond To Hims & Hers Health (HIMS) Appointing Regional Chief Medical Officers For Global Expansion
Benzinga - 2026-10-05
4 Health Care Stocks With Whale Alerts In Today’s Session
Yahoo - 2026-10-05
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo - 2026-10-02
Robinhood’s Tokenized Stocks Are Becoming a New Memecoin Trade: Report
Yahoo - 2026-10-01
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade
Yahoo - 2026-10-01
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
SeekingAlpha - 2026-09-30
Hims & Hers Goes Global - Renewed Growth Prospects With Margin Risks
Benzinga - 2026-09-30
10 Health Care Stocks With Whale Alerts In Today’s Session
SeekingAlpha - 2026-09-30
Hims & Hers: U.S. Revenue Reacceleration Is Reassuring, And Valuation Compression Is Compelling (Upgrade)
Yahoo - 2026-09-28
Hims & Hers Stock: 30% Growth Can’t Hide a Margin Problem
Yahoo - 2026-09-28
Signal: Fintech Firm Fit to Resume Run Higher
Yahoo - 2026-09-27
Can Hims & Hers Health (HIMS) Stay Cheap As Sales Face Scrutiny?
Yahoo - 2026-09-26
Hims & Hers Health (HIMS) Unveils AI Native Weight Loss Care Platform
Yahoo - 2026-09-26
Why Hims & Hers Health (HIMS) Is Back In The Spotlight
Yahoo - 2026-09-25
2 Reasons to Like HIMS (and 1 Not So Much)
Yahoo - 2026-09-24
Is the Market Right or Wrong About These 4 High Short Interest Stocks?
Benzinga - 2026-09-24
10 Health Care Stocks Whale Activity In Today’s Session
Yahoo - 2026-09-23
Hims and Hers Is Scaling Rapidly, But Management Needs To Address The Difficult Questions
Yahoo - 2026-09-22
Hims & Hers Just Went Negative on Profit. Twice.
Yahoo - 2026-09-21
Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges
Yahoo - 2026-09-21
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
Yahoo - 2026-09-19
Hims & Hers Chief Legal Officer Soleil Boughton Sells 6,236 Shares
Benzinga - 2026-09-18
9 Health Care Stocks Whale Activity In Today’s Session
SeekingAlpha - 2026-09-18
Veradermics: Buy Before The Catalysts
Yahoo - 2026-09-15
How FTC Data‑Sharing Complaint And Investor Lawsuits At Hims & Hers Health (HIMS) Have Changed Its Investment Story
Yahoo - 2026-09-15
Hims & Hers Health, Inc. (HIMS) Falls More Steeply Than Broader Market: What Investors Need to Know
Yahoo - 2026-09-15
Gap Inc. Appoints Kirsten Green to Board of Directors
Yahoo - 2026-09-14
HIMS Bulls Should Heed This Historic Chart Signal
SeekingAlpha - 2026-09-14
Hims & Hers: Pivot To Branded Distribution Is Eating The Margins Alive
Yahoo - 2026-09-13
I'm Calling It: Hims & Hers Health Will Soar 56% by the End of 2026
SeekingAlpha - 2026-09-12
FOMC Meeting Takes Center Stage As Earnings Fade
Yahoo - 2026-09-11
JPMorgan Tweaks Hims & Hers Stock Outlook on Key Risk
Yahoo - 2026-09-11
JPMorgan cautious on Hims & Hers on GLP-1 transition risk
Yahoo - 2026-09-10
Pump.fun Launches Custom Pairs for Tokenized Stocks
Yahoo - 2026-09-09
Why Is Hims & Hers Health (HIMS) Down 7.7% Since Last Earnings Report?
Yahoo - 2026-09-07
Here's Why Teladoc's Integrated Care Business Deserves More Attention
Benzinga - 2026-09-07
8 Health Care Stocks Whale Activity In Today’s Session
Yahoo - 2026-09-02
HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss
Yahoo - 2026-09-02
PAHC or LMAT: Which Is the Better Value Stock Right Now?
Yahoo - 2026-09-02
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
Yahoo - 2026-09-02
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands?
Yahoo - 2026-09-02
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders
Yahoo - 2026-09-02
GSK to Advance mRNA Influenza Vaccine Into Phase III Development
Yahoo - 2026-09-02
OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
Yahoo - 2026-09-02
Teva’s TEV-408 Hits Key Phase IIa Endpoint in Celiac Disease Study
Yahoo - 2026-09-02
J&J Faces Multiple Headwinds: Can the Healthcare Giant Sustain Growth?
Yahoo - 2026-09-02
Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?
Yahoo - 2026-09-02
Are Medical Stocks Lagging Cronos Group (CRON) This Year?
Yahoo - 2026-09-02
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Yahoo - 2026-09-02
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
Yahoo - 2026-09-02
Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?
Yahoo - 2026-09-02
Is This the Right Time to Add PBH Stock to Your Portfolio?
Yahoo - 2026-09-02
Caring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement
Yahoo - 2026-09-02
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
Yahoo - 2026-09-02
Trulieve Announces September 2026 Event Participation
Yahoo - 2026-09-02
BioAge Labs to Present at Upcoming Investor Conferences
Yahoo - 2026-09-02
Aurora Cannabis Urges Shareholders to Reject Curaleaf's Takeover Bid
Yahoo - 2026-09-02
Curaleaf Opens Boston Dispensary Near Downtown Crossing, Expanding Access for Patients in Massachusetts
Yahoo - 2026-09-02
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
SeekingAlpha - 2026-09-02
Tax Loss Harvesting: Tax Alpha With Raul Shah
Benzinga - 2026-09-02
Fraudulent Weight Loss Drugs: FDA Warns Against Mislabeled GLP-1 Medications
Yahoo - 2026-09-01
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
Yahoo - 2026-09-01
Hims & Hers falls after FDA crackdown on unapproved weight-loss drugs
Yahoo - 2026-09-01
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
Yahoo - 2026-09-01
Mid-cap biotechs join Trump’s latest round of drug pricing deals
Yahoo - 2026-09-01
Trump lines up MFN deals with nine mid-size pharmas on drug pricing push
Yahoo - 2026-09-01
Nasdaq tumbles as rising yields fuel market selloff
Yahoo - 2026-09-01
Harrow to Participate in Three Investor Conferences in September
Yahoo - 2026-09-01
Merck KGaA shares rise 1.7% after HSBC upgrades stock to Buy
Benzinga - 2026-09-01
How Did BONER Meme Coin Create One of Robinhood's Biggest Stories?
Yahoo - 2026-09-01
Winners Announced for IntelliNews Reputation Leaders Awards - Innovator of The Year
Yahoo - 2026-08-31
Hims & Hers’ Australia Expansion Adds Growth, But Execution Will Be Key
Yahoo - 2026-08-31
Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest
Yahoo - 2026-08-31
Hims Arrives in Australia, Bringing Personalised Care for Men Nationwide
Yahoo - 2026-08-31
Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment
Yahoo - 2026-08-31
Takeda Secures FDA Approval For First-In-Class Blood Cancer Drug
SeekingAlpha - 2026-08-31
Hims & Hers: A Healthcare Behemoth In The Making
Yahoo - 2026-08-29
Hims & Hers Health (HIMS) Stock Looks Like A Bargain On Sales But Mixed On Broader Checks
Yahoo - 2026-08-29
MarketBeat Week in Review – 08/24 - 08/28
Yahoo - 2026-08-29
Hims & Hers Health (HIMS) Is Down 14.6% After Raising Guidance Amid Privacy Scrutiny - What's Changed
Yahoo - 2026-08-28
Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company
Yahoo - 2026-08-28
Hims & Hers (HIMS)’ Weight-Loss Plans Results Penalties Over Visa (V) Credit Card Disputes
Yahoo - 2026-08-27
Unpacking Q2 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks
SeekingAlpha - 2026-08-27
Hims & Hers Is Growing Into Something Much Bigger
Yahoo - 2026-08-26
Curium acquisition of Lantheus backed by $5.375B of debt financing
Benzinga - 2026-08-26
Eli Lilly Announces Results From Real-World Study Of Overweight Or Obese Adults Over 55 Indicating That Staying On Zepbound For Weight Management Lowered Healthcare Costs Over Time
Yahoo - 2026-08-25
How GLP-1 Sales Could Play Out for Hims & Hers
Yahoo - 2026-08-25
Dell Stock's Massive Guidance Raise Has A Catch
Yahoo - 2026-08-25
Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group
Yahoo - 2026-08-25
Fosun Pharma Announces 2026 Interim Results
Yahoo - 2026-08-25
Hims & Hers Shares Tumble on Visa Dispute Crackdown
Yahoo - 2026-08-25
HIMS Stock Posts Worst Day In A Month As Visa Flags Disputes — But Analyst Says GLP-1 Users Are Sticking Around
Benzinga - 2026-08-24
Truist Securities Maintains Hold on Hims & Hers Health, Raises Price Target to $32
SeekingAlpha - 2026-08-21
Novo Nordisk: The Pill That Could Close The Gap With Lilly
Yahoo - 2026-08-21
HIMS Stock More Than Doubled in 6 Months: What's Driving the Rally?
Yahoo - 2026-08-21
Christina Lake Cannabis Announces Non-Binding Letter of Intent
Benzinga - 2026-08-21
Barclays Maintains Overweight on Hims & Hers Health, Lowers Price Target to $35
Yahoo - 2026-08-20
Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast
Yahoo - 2026-08-20
BioSyent Releases Financial Results for Q2 and H1 2026
Benzinga - 2026-08-19
Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access
Yahoo - 2026-08-19
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows
Yahoo - 2026-08-19
What Long-Term Investors Should Know About This Hims Insider Filing
Yahoo - 2026-08-19
A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know
Yahoo - 2026-08-19
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means.
SeekingAlpha - 2026-08-19
Hims & Hers: Buying The Margin Dip
Benzinga - 2026-08-19
'Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills' - WSJ
SeekingAlpha - 2026-08-18
Hims & Hers: Eucalyptus Deal Unlocks New Markets
SeekingAlpha - 2026-08-14
Hims & Hers Health's Next Act: Making Its Own Drugs Again
Yahoo - 2026-08-13
HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth Outlook
Yahoo - 2026-08-12
Hims & Hers Health (HIMS) Stock Looks Cheap Even With Legal Risk
ChartMill - 2026-08-12
AI Capex Roars On After Hours as Hormuz Stress Keeps Traders on Edge
SeekingAlpha - 2026-08-12
Hims & Hers: The Guidance Raise Doesn't Fix The Margin Problem
Yahoo - 2026-08-11
HIMS Stock Snaps 2-Day Climb: Analyst Says Record Subscriber Growth ‘Not Enough’ To Offset Margin Slide
Yahoo - 2026-08-11
Is Hims The Next Big Name In Peptides? Shares Topple Despite Sales Beat.
Yahoo - 2026-08-11
Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down
Yahoo - 2026-08-11
Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative?
Yahoo - 2026-08-11
Hims & Hers stock trims losses following quarterly results
Yahoo - 2026-08-11
Hims & Hers Q2 revenue beat offset by wider-than-expected loss
Benzinga - 2026-08-11
Citigroup Maintains Neutral on Hims & Hers Health, Lowers Price Target to $33
Yahoo - 2026-08-11
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks
SeekingAlpha - 2026-08-11
Wall Street Lunch: Anthropic To Watermark AI-Generated Content In EU
Yahoo - 2026-08-11
HIMS Q2 Earnings Call Focuses on AI and Global Expansion
Benzinga - 2026-08-11
Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $26
Yahoo - 2026-08-11
Hims & Hers' Revenue Growth Comes at a Cost
Benzinga - 2026-08-11
B of A Securities Maintains Neutral on Hims & Hers Health, Raises Price Target to $32
Yahoo - 2026-08-11
Hims & Hers Raises Outlook as Cash Flow Weakens
Yahoo - 2026-08-11
Hims & Hers Health, Inc. Q2 2026 Earnings Call Summary
Yahoo - 2026-08-11
Hims & Hers Health Earnings: What To Look For From HIMS
Benzinga - 2026-08-11
TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30
Benzinga - 2026-08-11
Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Raises Price Target to $28
Benzinga - 2026-08-11
Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst
Yahoo - 2026-08-11
Hims & Hers Q2 2026 earnings: loss despite revenue beat
Benzinga - 2026-08-11
Why Is Hims & Hers Health Stock Falling Tuesday?
Benzinga - 2026-08-11
OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
ChartMill - 2026-08-11
Wall Street Titans Line Up $500 Billion Behind Nvidia's AI Buildout
Benzinga - 2026-08-11
Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $42
Yahoo - 2026-08-11
Hims & Hers Health Inc (HIMS) (Q2 2026) Earnings Call Highlights: Revenue Surges 40% to ...
Yahoo - 2026-08-10
Hims & Hers Health Q2 Earnings Call Highlights
Yahoo - 2026-08-10
HIMS Retail Traders Flip Bullish After Q2 Print: Hims & Hers Keeps $225M Buyback Ready For Stock ‘Disconnect’
SeekingAlpha - 2026-08-10
Hims & Hers Health, Inc. (HIMS) Q2 2026 Earnings Call Transcript
SeekingAlpha - 2026-08-10
Hims & Hers Health, Inc. 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-08-10
HIMS Falls 6% After Hours On Q2 Loss— Eyes Oral Testosterone And Peptides Expansion
Yahoo - 2026-08-10
Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates
Benzinga - 2026-08-10
Rocket Lab USA, Hims & Hers, AST SpaceMobile, Archer Aviation and Plug Power: Why These 5 Stocks Are on Investors' Radars Today
Yahoo - 2026-08-10
Hims & Hers Lowers Profit Forecast, Shares Drop
Yahoo - 2026-08-10
Hims Stock Falls on Earnings. Why a Guidance Hike Isn’t Enough.
Yahoo - 2026-08-10
Hims & Hers shares fall after second-quarter wider-than-expected loss
Yahoo - 2026-08-10
Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
Benzinga - 2026-08-10
Hims & Hers Shares Drop After Mixed Q2 Earnings — Details
Benzinga - 2026-08-10
Hims & Hers Health Sees Q3 Sales $880.000M-$900.000M vs $793.071M Est
Benzinga - 2026-08-10
Hims & Hers Health Raises FY2026 Sales Guidance from $2.800B-$3.000B to $3.100B-$3.300B vs $2.928B Est
Benzinga - 2026-08-10
Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimate
Yahoo - 2026-08-10
Key Earnings Reports Ahead
Yahoo - 2026-08-10
Trading Week Awaits Inflation Reports Starting Wednesday
Yahoo - 2026-08-10
1 Healthcare Stock Worth Your Attention and 2 We Ignore
Yahoo - 2026-08-10
Stocks Mostly Up Pre-Bell as Traders Assess Middle East Developments, Await Key Inflation Data
Benzinga - 2026-08-10
Hims & Hers Stock Missed Estimates Last Quarter — Can It Turn the Page Tonight?
Benzinga - 2026-08-10
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Yahoo - 2026-08-09
SharkNinja Q2 Earnings Call Highlights
Yahoo - 2026-08-08
Eli Lilly and Company Q2 Earnings Call Highlights
Yahoo - 2026-08-08
Hims & Hers Health (HIMS) Responds To FTC Lawsuit Over Patient Data Use
Yahoo - 2026-08-07
Healthcare giant slashes key consultation fee to beat rivals
Yahoo - 2026-08-07
Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?
Yahoo - 2026-08-07
Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates
Yahoo - 2026-08-06
CareCloud, Inc. (CCLD) Lags Q2 Earnings and Revenue Estimates
Yahoo - 2026-08-06
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience
Benzinga - 2026-08-06
Hims & Hers Launches Intelligent AI Care Experience, Debuting With Hers Weight Loss Members To Deliver Personalized Guidance And Real-Time Progress Monitoring
Benzinga - 2026-08-06
Amazon Pharmacy Start Delivery GLP-1 Medications To Eligible Medicare Patients For $50 Per Month
Yahoo - 2026-08-05
Clover Health Investments Q2 Earnings Call Highlights
Yahoo - 2026-08-05
Hims & Hers Health, Inc. (HIMS) Declines More Than Market: Some Information for Investors
Benzinga - 2026-08-05
CVS Health Retools Its Weight Management Program To Make It Easier For Eligible Adults To Access Clinical Care, Navigate Medication Costs And Get Ongoing Support For GLP-1 Therapy
Yahoo - 2026-08-03
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
Yahoo - 2026-08-03
Is Hims & Hers Health Stock in Trouble?
Yahoo - 2026-08-03
Bearish Pressure Is Building Around These 3 Stocks
Yahoo - 2026-07-31
San Francisco's Hims & Hers sued over health data sharing and surprise prescription charges
Yahoo - 2026-07-31
2 Growth Stocks with Explosive Upside and 1 That Underwhelm
Benzinga - 2026-07-31
Hims & Hers Shares Rebound Friday: What's Driving the Move?
Yahoo - 2026-07-30
HIMS Stock Eyes 4-Week Losing Streak: Legal Woes Fuel ‘Very High’ Uncertainty As Analyst Sticks To ‘No Moat’ Call
SeekingAlpha - 2026-07-30
Hims & Hers Health: Still An Undervalued Company With Tremendous Upside
Yahoo - 2026-07-30
FTC lawsuit: Hims & Hers shared customer data with Meta, Snap
Yahoo - 2026-07-30
Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy?
Yahoo - 2026-07-30
2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore
Yahoo - 2026-07-30
Hims & Hers Health (HIMS) Faces FTC Lawsuit Over Health Data And Billing
SeekingAlpha - 2026-07-30
Hims & Hers Health: FTC Panic Gift
Benzinga - 2026-07-30
DarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027
Yahoo - 2026-07-29
Hims & Hers sued by FTC for sharing health data with Meta, Snap
Yahoo - 2026-07-29
FTC sues Hims & Hers, alleging it shared health data with Meta, Snap
Yahoo - 2026-07-29